Advertisement

Topics

Augmenix Announces First Prostate Cancer Patient Treated with SpaceOAR® Hydrogel in New Zealand

09:45 EDT 22 Jun 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Kathleen Kilgour Centre is the first cancer center in New Zealand to offer this innovative product to their community Augmenix, Inc., a medical technology company that develops, manufactures, and sells proprietary absorbable...

Other Sources for this Article

Augmenix
Eileen Gardner, RN, 781-902-1625
egardner@augmenix.com

NEXT ARTICLE

More From BioPortfolio on "Augmenix Announces First Prostate Cancer Patient Treated with SpaceOAR® Hydrogel in New Zealand"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Benign Prostatic Hyperplasia (BPH)
An enlarged prostate (benign prostatic enlargement (BPE) or benign prostatic hyperplasia (BPH)) is common in men after the age of about 50. Having an enlarged prostate does not mean you have cancer. In some cases, an enlarged prostate can cause the ...